The Pzifer $4 End Run

A few senators have now gotten into the scrum going on with Pfizer basically  blocking the generic release of Lipitor.    How Pfizer did this is pretty impressive.  By lowering the price to $4 and making that deal available to pharmacies and insurance companies, they effectively shut out the competition by price.   These techniques are not new.  Some pharmaceutical companies just pay off the generic company NOT to go ahead with the making the generic.  I don’t think Pfizer did anything illegal and at least it does give patients a pretty darn good drug for only $4 a month.  Now let’s see if they keep that price  for a while.   I also wonder how they can afford this when the drug used to have an average wholesale price over $100. Hmmm.

Douglas Farrago MD

Douglas Farrago MD is a full-time practicing family doc in Forest, Va. He started Forest Direct Primary Care where he takes no insurance and bills patients a monthly fee. He is board certified in the specialty of Family Practice. He is the inventor of a product called the Knee Saver which is currently in the Baseball Hall of Fame. The Knee Saver and its knock-offs are worn by many major league baseball catchers. He is also the inventor of the CryoHelmet used by athletes for head injuries as well as migraine sufferers. Dr. Farrago is the author of four books, two of which are the top two most popular DPC books. From 2001 – 2011, Dr. Farrago was the editor and creator of the Placebo Journal which ran for 10 full years. Described as the Mad Magazine for doctors, he and the Placebo Journal were featured in the Washington Post, US News and World Report, the AP, and the NY Times. Dr. Farrago is also the editor of the blog Authentic Medicine which was born out of concern about where the direction of healthcare is heading and the belief that the wrong people are in charge. This blog has been going daily for more than 15 years Article about Dr. Farrago in Doximity Email Dr. Farrago – [email protected]

You may also like...

1 Response

  1. Daniel says:

    I think that that’s actually a fantastic development. With the potential competition of generics coming up, I’d like to see if this becomes a repeat performance.

Get plugin